# Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes

> **NCT04133922** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of Virginia**

## Conditions studied

- Type 1 Diabetes
- Insulin Sensitivity/Resistance

## Interventions

- **DRUG:** GLP-1
- **DRUG:** Insulin
- **DRUG:** Dextrose 20 % in Water

## Key facts

- **NCT ID:** NCT04133922
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-10-14
- **Primary completion:** 2023-10
- **Final completion:** 2024-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** the study drug could not be obtained
- **Last updated:** 2022-03-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04133922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04133922, "Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04133922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*